InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Dugan Margaret, 董事. Director active across 3 companies, notably BeiGene, Ltd.. Cumulatively, 9 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €81k. Activity tracked since 22 June 2022. The latest transaction was disclosed on 22 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Margaret Dugan serves as a Board Member at BeiGene, Ltd. In this role, she is involved in overseeing the company's operations and defining its strategy. BeiGene, Ltd. is a biopharmaceutical company focused on research and development. Margaret brings her experience in corporate governance to the board.